BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abu-Hilal M, Tawaker J. Portal hypertension secondary to myelofibrosis with myeloid metaplasia: A study of 13 cases. World J Gastroenterol 2009; 15(25): 3128-3133 [PMID: 19575492 DOI: 10.3748/wjg.15.3128]
URL: https://www.wjgnet.com/1007-9327/full/v15/i25/3128.htm
Number Citing Articles
1
Kohtaro Toyama, Takeki Mitsui, Akihiko Yokohama, Takayuki Saitoh, Hideki Uchiumi, Hiroshi Handa, Masataka Sakuraya, Hirokazu Murakami, Yoshihisa Nojima, Norifumi Tsukamoto. Polycythemia Vera Terminating in Refractory AscitesThe Kitakanto Medical Journal 2012; 62(2): 159 doi: 10.2974/kmj.62.159
2
Ahmet Burak Toros, Serkan Gokcay, Guven Cetin, Muhlis Cem Ar, Yesim Karagoz, Besir Kesici. Portal Hypertension and Myeloproliferative Neoplasms: A Relationship RevealedISRN Hematology 2013; 2013: 1 doi: 10.1155/2013/673781
3
S. Rajesh, Amar Mukund, Binit Sureka, Kalpana Bansal, Maxime Ronot, Ankur Arora. Non-cirrhotic portal hypertension: an imaging reviewAbdominal Radiology 2018; 43(8): 1991 doi: 10.1007/s00261-018-1570-8
4
Ananya Panda, Sheragaru Hanumanthappa Chandrashekhara, Aruna Nambirajan, Pravas Mishra. Idiopathic myelofibrosis with disseminated hepatosplenic, mesenteric, renal and pulmonary extramedullary haematopoeisis, portal hypertension and tuberculosis: initial presentation and 2 years follow-upBMJ Case Reports 2016; : bcr2016217854 doi: 10.1136/bcr-2016-217854
5
Yolandi Rautenbach, Amelia Goddard, Sarah J. Clift. Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dogVeterinary Clinical Pathology 2017; 46(1): 46 doi: 10.1111/vcp.12430
6
Debanjali Mitra, James A. Kaye, Lance T. Piecoro, Jennifer Brown, Kelly Reith, Tariq I. Mughal, Nicholas J. Sarlis. Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record reviewCancer Medicine 2013; 2(6): 889 doi: 10.1002/cam4.136
7
Ankur Varma, Susan C. Abraham, Rohtesh S. Mehta, Neeraj Y. Saini, Medhavi Honhar, Munazza Rashid, Julianne Chen, Samer A. Srour, Qaiser Bashir, Gabriela Rondon, Betul Oran, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Sairah Ahmed, David Marin, Issa F. Khouri, Stefan O. Ciurea, Muzaffar H. Qazilbash, Katy Rezvani, Paolo Anderlini, Borje S. Andersson, Elizabeth J. Shpall, Richard E. Champlin, Uday R. Popat. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entityBlood Advances 2020; 4(7): 1296 doi: 10.1182/bloodadvances.2019000638
8
Claire Harrison, Ruben Mesa, David Ross, Adam Mead, Clodagh Keohane, Jason Gotlib, Srdan Verstovsek. Practical management of patients with myelofibrosis receiving ruxolitinibExpert Review of Hematology 2013; 6(5): 511 doi: 10.1586/17474086.2013.827413
9
Dimitrios N Samonakis, Aikaterini Mantaka,, Dimitrios Tsetis,, Adam Hatzidakis, Elias A Kouroumalis. Successful management of refractory gastric variceal bleeding via a combined percutaneous approach in sinistral portal hypertensionGastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00294
10
Marco Casaccia, Rosario Fornaro, Marco Frascio, Denise Palombo, Cesare Stabilini, Emma Firpo, Ezio Gianetta. Peritoneal carcinomatosis-like implants of extramedullary hematopoiesis. An insolite occurrence during splenectomy for myelofibrosisInternational Journal of Surgery Case Reports 2017; 41: 9 doi: 10.1016/j.ijscr.2017.09.030
11
Kit Man Wong, Eshetu G. Atenafu, Dennis Kim, John Kuruvilla, Jeffrey H. Lipton, Hans Messner, Vikas Gupta. Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell TransplantationBiology of Blood and Marrow Transplantation 2012; 18(10): 1589 doi: 10.1016/j.bbmt.2012.04.011
12
Rashmi Parikh, Nalini Bansal, Rajeev Sen. Liver histopathology in scope of hematological disordersIndian Journal of Pathology and Microbiology 2023; 66(4): 683 doi: 10.4103/ijpm.ijpm_856_22
13
Xiu-Qing Wei, Zong-Heng Zheng, Yi Jin, Jin Tao, Kodjo-Kunale Abassa, Zhuo-Fu Wen, Chun-Kui Shao, Hong-Bo Wei, Bin Wu. Intestinal obstruction caused by extramedullary hematopoiesis and ascites in primary myelofibrosisWorld Journal of Gastroenterology 2014; 20(33): 11921-11926 doi: 10.3748/wjg.v20.i33.11921
14
Douglas Motomura, Tasha Kulai, Ian Epstein. Esophageal Variceal Hemorrhage Secondary to Post-Polycythemic MyelofibrosisJournal of the Canadian Association of Gastroenterology 2018; 1(3): 95 doi: 10.1093/jcag/gwy016
15
Adeline Normand, Yannick Le Bris, Delphine Loussouarn, Jérôme Gournay, Jean-François Mosnier. Obliteration of liver sinusoids through platelet aggregates associated to extramedullary haematopoiesis in myeloid neoplasmsVirchows Archiv 2024;  doi: 10.1007/s00428-024-03844-2
16
Ken Ogasawara, William B. Smith, Christine Xu, Jian Yin, Maria Palmisano, Gopal Krishna. Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairmentCancer Chemotherapy and Pharmacology 2020; 85(6): 1109 doi: 10.1007/s00280-020-04084-2
17
Splenomegaly Secondary to Myeloproliferative Neoplasms and Portal HypertensionClinical Lymphoma Myeloma and Leukemia 2015; 15(6): e135 doi: 10.1016/j.clml.2014.10.005
18
Rinkle R Gemnani, Avinash Parepalli, Sunil Kumar, Sourya Acharya, Samarth Shukla. Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal HypertensionCureus 2023;  doi: 10.7759/cureus.40692
19
Fabio P. S. Santos, Constantine S. Tam, Hagop Kantarjian, Jorge Cortes, Deborah Thomas, Raphael Pollock, Srdan Verstovsek. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformationLeukemia & Lymphoma 2014; 55(1): 121 doi: 10.3109/10428194.2013.794269
20
R. Ennaifer, M. Sabbah, R. Hefaiedh, H. Romdhane, N. Bel Hadj. Exudative ascites as presenting manifestation of latent essential thrombocytemiaJCC Open 2013; 1(1): 4 doi: 10.1016/j.jcco.2012.11.001
21
Hidetaka Hamasaki, Shuichi Mishima, Hidekatsu Yanai. Hyperinsulinemia and insulin resistance in a patient with type 2 diabetes complicated with myelofibrosisWorld Journal of Diabetes 2012; 3(8): 156-157 doi: 10.4239/wjd.v3.i8.156
22
Xiu He Lv, Liang Liang Ma, Wei Yun Fu, Yan Xie. Splenic marginal zone lymphoma leads to sinistral portal hypertensionJournal of Digestive Diseases 2019; 20(1): 45 doi: 10.1111/1751-2980.12696
23
Matthew Yan, Holly Geyer, Ruben Mesa, Ehab Atallah, Jeannie Callum, Justyna Bartoszko, Karen Yee, Manjula Maganti, Florence Wong, Vikas Gupta. Clinical Features of Patients With Philadelphia-Negative Myeloproliferative Neoplasms Complicated by Portal HypertensionClinical Lymphoma Myeloma and Leukemia 2015; 15(1): e1 doi: 10.1016/j.clml.2014.04.004
24
Sadia Sultan, Syed Mohammed Irfan. Primary Idiopathic Myelofibrosis: Clinico-Epidemiological Profile and Risk Stratification in Pakistani PatientsAsian Pacific Journal of Cancer Prevention 2016; 16(18): 8629 doi: 10.7314/APJCP.2015.16.18.8629
25
Takuya Kihara, Takaaki Sugihara, Suguru Ikeda, Yukako Matsuki, Takakazu Nagahara, Kenji Oyama, Jun-ichi Okano, Hajime Isomoto. A case of portal hypertension complicated with <i>de novo</i> acute myeloid leukemiaKanzo 2022; 63(9): 409 doi: 10.2957/kanzo.63.409
26
J. Lemaire, A. Rosière, C. Bertrand, B. Bihin, J. E. Donckier, L. A. Michel. Surgery for massive splenomegalyBJS Open 2017; 1(1): 11 doi: 10.1002/bjs5.1
27
Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasmsClinical and Molecular Hepatology 2020; 26(1): 78 doi: 10.3350/cmh.2019.0078